Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000101.xml
Zeitschrift für Phytotherapie 2022; 43(S 01): S24-S25
DOI: 10.1055/a-1792-9136
DOI: 10.1055/a-1792-9136
Referate | Phytotherapie 2022 – innovativ
Is Nigella Sativa L. (Black Seed) a Phyto-Therapeutic Option in the Treatment of Asthma? A Case Study in Saudi Arabia
Background
Clinical research using herbal medicines requires specific considerations such as the method of production, which leads to chemical and pharmacological variability. Asthma is a leading chronic respiratory disease, remains sub-optimally controlled despite available conventional treatments. Nigella sativa L. (NS) is a herbal medicine traditionally used in asthma and for a multitude of other indications. It has claims associated with a diverse range of major and minor health problems [1] often associated with chronic inflammatory processes [2]. However, rigorous scientific evidence is often lacking.
Publication History
Article published online:
13 June 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Dajani EZ et al.. Overview of the human investigations of Nigella sativa (black seeds): A complementary drug with historical and clinical significance. Gen Int Med Clin Innov 2018; 3 DOI: 10.15761/GIMCI.1000171.
- 2 Gholamnezhad Z et al.. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. J Ethnopharmacol 2016; 190: 372-386 DOI: 10.1016/j.jep.2016.06.061.
- 3 Koshak AE et al.. Comparative immunomodulatory activity of Nigella sativa L. preparations on proinflammatory mediators: A focus on asthma. Front Pharmacol 2018; 9: 1705 DOI: 10.3389/fphar.2018.01075.
- 4 Koshak AE et al.. Nigella sativa supplementation improves asthma control and biomarkers: A randomized, double-blind, placebo-controlled trial. Phytother Res 2017; 31: 403-409 DOI: 10.1002/ptr.5761.